Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Arthur Bert"'
Autor:
Thomas El Jammal, Yvan Jamilloux, Mathieu Gerfaud-Valentin, Gaëlle Richard-Colmant, Emmanuelle Weber, Arthur Bert, Géraldine Androdias, Pascal Sève
Publikováno v:
Diagnostics, Vol 11, Iss 7, p 1240 (2021)
Sarcoidosis is a systemic granulomatous disease of unknown cause characterized by a wide variety of presentations. Its diagnosis is based on three major criteria: a clinical presentation compatible with sarcoidosis, the presence of non-necrotizing gr
Externí odkaz:
https://doaj.org/article/ac50c88b27de4cba9b8f11960b073c9b
Autor:
Gaëlle Fossard, Emilie Blond, Marie Balsat, Stéphane Morisset, Stéphane Giraudier, Martine Escoffre-Barbe, Hélène Labussière-Wallet, Maël Heiblig, Arthur Bert, Madeleine Etienne, Jocelyne Drai, Mohamad Sobh, Isabelle Redonnet-Vernhet, Jean-Christophe Lega, François-Xavier Mahon, Gabriel Etienne, Franck Emmanuel Nicolini
Publikováno v:
Haematologica, Vol 101, Iss 3 (2016)
Externí odkaz:
https://doaj.org/article/fbdaf4f81f494b2b82929c051c8fa3ec
Publikováno v:
Revue du Rhumatisme Monographies. 88:257-266
Resume Le rhumatologue et l’interniste peuvent etre sollicites tant pour le diagnostic etiologique que pour la prise en charge therapeutique d’une uveite. L’etude prospective ULISSE (Uveites: evaluation clinique et medico-economique d’une str
Autor:
Stéphane Giorgiutti, Robin Jacquot, Thomas El Jammal, Arthur Bert, Yvan Jamilloux, Laurent Kodjikian, Pascal Sève
Publikováno v:
Journal of Clinical Medicine. 12:3194
Sarcoidosis is an inflammatory disease that involves the eyes in 10–55% of cases, sometimes without systemic involvement. All eye structures can be affected, but uveitis is the most common ocular manifestation and causes vision loss. The typical op
Autor:
Arthur Bert, Gaëlle Richard-Colmant, Yvan Jamilloux, Pascal Sève, Thomas El Jammal, Géraldine Androdias, Mathieu Gerfaud-Valentin, Emmanuelle Weber
Publikováno v:
Diagnostics, Vol 11, Iss 1240, p 1240 (2021)
Diagnostics
Volume 11
Issue 7
Diagnostics
Volume 11
Issue 7
Sarcoidosis is a systemic granulomatous disease of unknown cause characterized by a wide variety of presentations. Its diagnosis is based on three major criteria: a clinical presentation compatible with sarcoidosis, the presence of non-necrotizing gr
Publikováno v:
The American Journal of Medicine. 134:1493-1494
Autor:
Franck E. Nicolini, Arthur Bert, Mohamad Sobh, Hélène Labussière-Wallet, Marie Balsat, Maël Heiblig
Publikováno v:
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia ISBN: 9784431557135
Despite the remarkable success of tyrosine kinase inhibitors (TKIs) in the treatment of CML, patients that do not respond or do not tolerate well these agents accumulate, and new options have to be found to avoid these situations. In this chapter, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::169d2b962c9a9e44d4f1374a067227d8
https://doi.org/10.1007/978-4-431-55714-2_9
https://doi.org/10.1007/978-4-431-55714-2_9
Autor:
Franck E. Nicolini, Mohamad Sobh, Arthur Bert, Hélène Labussière-Wallet, Emilie Blond, Jocelyne Drai, Marie Balsat, Isabelle Redonnet-vernhet, Maël Heiblig, Madeleine Etienne, Gaelle Fossard, Stephane Morisset, Francois-Xavier Mahon, Gabriel Etienne, Stéphane Giraudier, Jean-Christophe Lega, Martine Escoffre-Barbe
Publikováno v:
Haematologica 3 (101), E86-E90. (2016)
Haematologica
Haematologica, Ferrata Storti Foundation, 2016, 101 (3), pp.e86-90. ⟨10.3324/haematol.2015.135103⟩
Haematologica
Haematologica, Ferrata Storti Foundation, 2016, 101 (3), pp.e86-90. ⟨10.3324/haematol.2015.135103⟩
Fossard, Gaelle Blond, Emilie Balsat, Marie Morisset, Stephane Giraudier, Stephane Escoffre-Barbe, Martine Labussiere-Wallet, Helene Heiblig, Mael Bert, Arthur Etienne, Madeleine Drai, Jocelyne Sobh, Mohamad Redonnet-Vernhet, Isabelle Lega, Jean-Chri
Publikováno v:
Strategy & Leadership. 31:42-49
Today, with years of corporate experience in managing mergers and acquisitions, there is little excuse for deals that don’t create value. Regrettably failure is the case more often than not. Depending on the industry, a top‐performing merger can